Colchicine and Dymista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colchicine (colchicine) and Dymista (azelastine hydrochloride; fluticasone propionate). Common drug interactions include chronic kidney disease among females and pulmonary tuberculosis among males.

The phase IV clinical study analyzes what interactions people have when they take Colchicine and Dymista. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Colchicine?

Colchicine has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 21,826 Colchicine users. Check the latest studies of Colchicine.

What is Dymista?

Dymista has active ingredients of azelastine hydrochloride; fluticasone propionate. It is often used in allergies. eHealthMe is studying from 4,407 Dymista users. Check the latest studies of Dymista.



On Jul, 29, 2026

26 people who take Colchicine and Dymista together, and have interactions are studied.

Colchicine and Dymista drug interactions.

What are the common drug interactions of Colchicine and Dymista, by gender? *:

female:

  1. Chronic kidney disease
  2. Muscle spasms (muscle contraction)
  3. Diarrhoea
  4. Dry eye (lack of adequate tears)
  5. Eye pain
  6. Muscle tightness
  7. Vomiting
  8. Abdominal pain
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Decreased appetite

male:

  1. Pulmonary tuberculosis (lungs tuberculosis)
  2. Chronic kidney disease
  3. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  4. Muscular weakness (muscle weakness)
  5. Nausea (feeling of having an urge to vomit)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Renal failure (kidney dysfunction)
  8. Renal tubular necrosis (death of kidney tubules)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Tenderness (pain or discomfort when an affected area is touched)

What are the common drug interactions of Colchicine and Dymista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pulmonary tuberculosis (lungs tuberculosis)
  2. Tuberculosis (a bacterial infection by mycobacterium tuberculosis)

40-49:

  1. Abdominal pain
  2. Depression
  3. Diarrhoea
  4. Foot fracture
  5. Furuncle (infection of the hair follicle)
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Hepatic vein thrombosis (obstruction in the veins of the liver caused by a blood clot)
  8. Hospitalisation
  9. Hunger
  10. Limb injury

50-59:

  1. Chronic kidney disease
  2. Renal tubular necrosis (death of kidney tubules)

60+:

  1. Chronic kidney disease
  2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  3. Renal failure (kidney dysfunction)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Vomiting projectile
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Cardiac failure
  9. Cardiac failure congestive
  10. Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 30.77%
  2. High Blood Pressure: 6 people, 23.08%
  3. Pain: 5 people, 19.23%
  4. Cough: 5 people, 19.23%
  5. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 5 people, 19.23%
  6. Hordeolum (small collection of pus (abscess) on the eyelid): 5 people, 19.23%
  7. High Blood Cholesterol: 4 people, 15.38%
  8. Indigestion: 4 people, 15.38%
  9. Chondrocalcinosis (crystal deposition disease): 3 people, 11.54%
  10. Asthma: 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Colchicine and Dymista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Colchicine and Dymista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Colchicine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dymista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colchicine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dymista and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on colchicine and azelastine hydrochloride; fluticasone propionate (the active ingredients of Colchicine and Dymista, respectively), and Colchicine and Dymista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: